The same month, Teva announced the ¥40 billion purchase of a majority stake in Japanese generic drug company Taiyo Pharmaceutical Industry, a move to secure a Japan-local production facility. Teva completed the $934 million acquisition in July 2011.
In the same month, Teva announced its ¥40 billion purchase of a majority share in Japanese generic pharmaceutical company Taiyo Pharmaceutical Industry, with the goal of securing a local manufacturing site. Teva completed this acquisition in July 2011 for $934 million.